Infracoccygeal sacropexy improves the quality of life of women with uterine prolapse.
This study evaluated the quality of life following infracoccygeal sacropexy in patients with pelvic organ prolapse by using the short versions of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7). We prospectively studied 35 women who underwent infracoccygeal sacropexy for the management of uterine or stump prolapse. The recurrence of pelvic organ prolapse was assessed 6 months after surgery. The prolapse, urinary, and colorectal scales of PFDI-20 and PFIQ-7 were assessed at baseline and 6 months after surgery. The preoperative grade of prolapse was 2.7+/-0.7; 6 months after the surgery, it decreased to 0.4+/-0.6. PFDI-20 and its 3 respective scales demonstrated statistically significant improvements following the surgery (P<0.05). (POPDI-6 score, 57.7+/-12.3 vs. 41.6+/-8.3; CRADI-8 score, 36.6+/-7.2 vs. 28.5+/-3.2; and UDI-6 score, 57.1+/-14.8 vs. 33.9+/-7.6; preoperatively vs. postoperatively) The three scales of PFIQ-7, namely, UIQ-7, CRAIQ-7, and POPIQ-7, exhibited statistically significant improvements after the surgery (UIQ-7 score, 22.3+/-5.6 vs. 9.8+/-3.8; CRAIQ-7 score, 11.1+/-4.2 vs. 28.8+/-7.1; and POPIQ-7 score, 38.7+/-12.5 vs. 16.9+/-7.8; preoperatively vs. postoperatively). Infracoccygeal sacropexy was an effective method for the management of uterine/stump prolapse; further, it improved the quality of life of women with pelvic organ prolapse.